This was followed by clinical expression and survival analyses, which validated eight genes (IGFBP3, CD72, SERPINH1, CHRDL2, LRP11, SPARCL1, DBI and HYAL1) as significant CRC candidates. The gene discussed is LRP11; the disease is colorectal carcinoma.